Clinical Trials Directory

Trials / Terminated

TerminatedNCT04759989

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.

Detailed description

Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1 at present, there are no robust data to support whether dosing based on actual body weight or an alternative correction formula (ideal body weight, adjusted body weight) is superior. FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative resuscitation strategies for obese patients with septic shock, looking at feasibility and safety of different weight-based approaches. Subject treatment assignment will not be blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).

Conditions

Interventions

TypeNameDescription
PROCEDUREActual Body Weight Dosing30cc/kg initial bolus calculated using Actual Body Weight
PROCEDUREAdjusted Body Weight Dosing30cc/kg initial bolus calculated using Adjusted Body Weight
PROCEDUREIdeal Body Weight Dosing30cc/kg initial bolus calculated using Ideal Body Weight

Timeline

Start date
2021-06-01
Primary completion
2022-04-25
Completion
2022-05-25
First posted
2021-02-18
Last updated
2022-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04759989. Inclusion in this directory is not an endorsement.